AU2002316552A1 - Inhibitor of t cell activation - Google Patents

Inhibitor of t cell activation

Info

Publication number
AU2002316552A1
AU2002316552A1 AU2002316552A AU2002316552A AU2002316552A1 AU 2002316552 A1 AU2002316552 A1 AU 2002316552A1 AU 2002316552 A AU2002316552 A AU 2002316552A AU 2002316552 A AU2002316552 A AU 2002316552A AU 2002316552 A1 AU2002316552 A1 AU 2002316552A1
Authority
AU
Australia
Prior art keywords
inhibitor
cell activation
activation
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002316552A
Inventor
Fulvio D'acquisto
Sankar Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU2002316552A1 publication Critical patent/AU2002316552A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
AU2002316552A 2001-07-02 2002-07-02 Inhibitor of t cell activation Abandoned AU2002316552A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30247401P 2001-07-02 2001-07-02
US60/302,474 2001-07-02
PCT/US2002/021215 WO2003004612A2 (en) 2001-07-02 2002-07-02 Inhibitor of t cell activation

Publications (1)

Publication Number Publication Date
AU2002316552A1 true AU2002316552A1 (en) 2003-01-21

Family

ID=23167861

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002316552A Abandoned AU2002316552A1 (en) 2001-07-02 2002-07-02 Inhibitor of t cell activation

Country Status (2)

Country Link
AU (1) AU2002316552A1 (en)
WO (1) WO2003004612A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
WO2005017146A1 (en) * 2003-08-19 2005-02-24 Celestar Lexico-Sciences, Inc. Interaction inhibitors, method of detecting interaction inhibitor and kit for detecting interaction inhibitor
DE102005020754B3 (en) * 2005-05-02 2007-01-11 Altana Pharma Ag Cellular assay method for the identification of PKCtheta inhibitors
US8148067B2 (en) 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
US8785648B1 (en) 2010-08-10 2014-07-22 The Regents Of The University Of California PKC-epsilon inhibitors
US20150099645A1 (en) * 2012-03-14 2015-04-09 Stephen Marx Means and methods for diagnostics and therapeutics of diseases
EP3180003B1 (en) 2014-07-01 2022-01-12 The Regents of the University of California Pkc-epsilon inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190869B1 (en) * 1999-10-26 2001-02-20 Isis Pharmaceuticals, Inc. Antisense inhibition of protein kinase C-theta expression
AU2460601A (en) * 1999-12-27 2001-07-09 La Jolla Institute For Allergy Methods for identifying agents capable of modulating protein kinase c theta (pkctheta) activity

Also Published As

Publication number Publication date
WO2003004612A2 (en) 2003-01-16
WO2003004612A3 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
AU2002258941A1 (en) Methods of enhancing cell responsiveness
AU2001258771A1 (en) -secretase inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
AU2002339348A1 (en) Inhibition of STAT-1
AU2002350217A1 (en) Glycinamides as factor xa inhibitors
AU2002333233A1 (en) Interaction inhibitors of tcf-4 with beta-catenin
AU2003236991A1 (en) Representations of processes
AU2002317418A1 (en) Cell enumeration
AU2003244750A1 (en) Polymerisation inhibitor
AU2002304853A1 (en) Substituted benzopyranones as telomerase inhibitors
AU2002322802A1 (en) Thrombin inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2002316552A1 (en) Inhibitor of t cell activation
AU2002360673A1 (en) Gp41 inhibitor
AU2002222933A1 (en) Inhibitors of factor xa
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2003244080A1 (en) Phosphodiesterase inhibitor
AU2002351076A1 (en) Thrombin inhibitors
AU2002348501A1 (en) Factor xa inhibitor
AU2003287188A1 (en) Activation of hcv-specific cells
AU2002305868A1 (en) Inhibitors of reggamma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase